Learning objectives
• To learn mammographic and sonographic features and magnetic resonance imaging (MRI) findings of metaplastic breast cancer (MBC)
• To identify the differences and the similarities in the presentation between MBC and invasive breast cancer (IBC) not otherwise specified (NOS)
• To learn the clinicopathologic findings of MBC
Background
• Breast cancer is classified into two major histological groups: IBC-NOS and special types of IBC
• The main difference that distinguishes these groups is that IBC-NOS is a diagnosis of exclusion that comprises adenocarcinomas that fail to exhibit sufficient characteristics to warrant their classification in one of the special types
• Special types of carcinoma account for up to 25% of all IBC and are associated with distinct biological features
• One of these special types of IBC is MBC
• MBC was officially...
Findings and procedure details
• Diagnosis is made by associating clinical, mammographic, sonographic, MRI and histopathological findings
• Typical clinical findings of MBC includes a rapidly growing palpable breast mass
• It can mimic a benign breast lesion (such as fibroadenoma) in the imaging methods conventionally used in the evaluation of the breast
• Typical mammographic findings of MBC includes a round or irregular dense mass, with circumscribed or indistinct margins, rarely presenting calcifications
• Typical sonographic findings of MBC includes an irregular microlobulated hypoechoic mass or complex cystic...
Conclusion
• Breast cancer is histologically classified in IBC-NOS or special type of IBC. MBC is one of these special types
• MBC is characterized by differentiation of the neoplastic epithelium into squamous or mesenchymal phenotype
• Diagnosis is made by associating clinical, imaging and histopathological findings
• Most of the patients look for medical care after presenting a rapidly growing palpable mass
• MBC can mimic a benign breast lesion in the imaging methods conventionally used in the evaluation of the breast
• Compared to...
Personal information and conflict of interest
V. S. D. M. Ogata; São Paulo, SP/BR - nothing to disclose R. A. E. K. Matsumoto; Sao Paulo/BR - nothing to disclose C. Shimizu; São Paulo, SP/BR - nothing to disclose N. de Barros; Sao Paulo, SAO PAULO/BR - nothing to disclose P. H. H. Souza; São Paulo, SÃO PAULO/BR - nothing to disclose
References
• "Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies" Schwartz et al. Experimental Hematology & Oncology (2013) 2:31
• "Metaplastic carcinoma of the breast: an immunohistochemical study", Altaf et al. Diagnostic Pathology (2014) 9:139
• "Metaplastic carcinoma of the breast: A case series and review of the literature", D.E. Boler et al. Journal of Oncological Sciences 2 (2016) 38-42
• "Clinicopathological features of metaplastic breast carcinoma", O. A. Hasdemir, et al. Adv Clin Exp Med. (2018) 27(4):509–513
• "Metaplastic Carcinoma of the...